Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sertraline versus other antidepressive agents for depression.
Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C. Cipriani A, et al. Among authors: nakagawa a. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006117. doi: 10.1002/14651858.CD006117.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006117. doi: http://dx.doi.org/10.1002/14651858.CD006117 PMID: 19370626 Updated. Review.
Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group. Nakagawa A, et al. CNS Drugs. 2008;22(7):587-602. doi: 10.2165/00023210-200822070-00004. CNS Drugs. 2008. PMID: 18547127 Review.
Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
Cipriani A, Furukawa TA, Geddes JR, Malvini L, Signoretti A, McGuire H, Churchill R, Nakagawa A, Barbui C; MANGA Study Group. Cipriani A, et al. Among authors: nakagawa a. J Clin Psychiatry. 2008 Nov;69(11):1732-42. doi: 10.4088/jcp.v69n1108. Epub 2008 Nov 4. J Clin Psychiatry. 2008. PMID: 19026250 Review.
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group. Watanabe N, et al. Among authors: nakagawa a. J Clin Psychiatry. 2008 Sep;69(9):1404-15. doi: 10.4088/jcp.v69n0908. J Clin Psychiatry. 2008. PMID: 19193341 Review.
Escitalopram versus other antidepressive agents for depression.
Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R, Barbui C. Cipriani A, et al. Among authors: nakagawa a. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006532. doi: 10.1002/14651858.CD006532.pub2. Cochrane Database Syst Rev. 2009. PMID: 19370639 Free PMC article. Review.
Milnacipran versus other antidepressive agents for depression.
Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA. Nakagawa A, et al. Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006529. doi: 10.1002/14651858.CD006529.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588396 Free PMC article. Review.
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; MANGA (Meta-Analysis of New Generation Antidepressants) Study Group. Watanabe N, et al. Among authors: nakagawa a. CNS Drugs. 2010 Jan;24(1):35-53. doi: 10.2165/11319480-000000000-00000. CNS Drugs. 2010. PMID: 20030418 Review.
1,272 results